- The 8 States Most Likely to Legalize Marijuana Next
- BlackBerry Is Finally Realizing Smartphones Aren't the Answer
- Express Scripts and AbbVie Drug-Pricing Deal Might Devastate Biotech Bull Market
- Dow 18,000: Why This Market Rally May Never Happen Again
- Gilead Sciences Is Not a Buy; It's Heading Lower on Price War: Jim Cramer
World markets reap gains as U.S. stocks remain flat.
The fund move could bolster its fee-based business.
The stock looks exposed to a stock market downturn, though.
Silver Lake mulls its options as its pares its Nasdaq stake.
The former KKR bigwig's fund heads for a risky debt niche.
Brokerage stocks rise even as profit estimates sink.
The hedge fund is down 20% this year after several bad bets.
The National Stock Exchange is getting money from Wall Street.
Apollo founder Michael Gross eyes blank-check bonanza.
The investment firm reports a strong quarter following its IPO.